Analyst Consensus ?
ConsensusHold30 ratings
Bullish1343.3%
Neutral1756.7%
Bearish00.0%
FN2 Earnings Intelligence
CenterPoint Energy, Inc. (CNP) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Keybanc | Overweight | Overweight | Maintain | Jul 23, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Jul 22, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Jul 16, 2026 |
| Truist Securities | Buy | Buy | Maintain | May 18, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | May 4, 2026 |
| Jefferies | Buy | Buy | Maintain | Apr 16, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Apr 15, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Apr 15, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jan 20, 2026 |
| UBS | Buy | Buy | Maintain | Dec 17, 2025 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Oct 24, 2025 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Oct 21, 2025 |
| Mizuho | Neutral | Neutral | Maintain | Sep 30, 2025 |
| Guggenheim | Buy | Buy | Maintain | Feb 21, 2024 |
| RBC Capital | Outperform | Outperform | Maintain | Sep 6, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Apr 26, 2022 |
| Citigroup | Neutral | Neutral | Maintain | Feb 23, 2022 |
| Goldman Sachs | Neutral | Buy | Downgrade | Jan 13, 2022 |
| CFRA | Hold | Hold | Maintain | May 7, 2020 |
| SunTrust Robinson Humphrey | Hold | Buy | Downgrade | Nov 15, 2019 |
| Guggenheim Securities | Neutral | Buy | Downgrade | Nov 15, 2019 |
| Bank of America | Neutral | Buy | Downgrade | Nov 15, 2019 |
| Argus | Buy | Buy | Maintain | May 5, 2018 |
| Deutsche Bank | Hold | Hold | Maintain | Aug 8, 2016 |
| Tudor Pickering | Hold | Buy | Downgrade | Jul 5, 2016 |
| Argus Research | Buy | Buy | Maintain | Mar 24, 2016 |
| Macquarie | Neutral | Neutral | Maintain | Jan 28, 2016 |
| Ladenburg Thalmann | Neutral | Neutral | Maintain | Jul 7, 2015 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Nov 26, 2013 |
| Bank oferica | Buy | Buy | Maintain | May 4, 2012 |
Upside is calculated against the persisted current price $42.02. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Wolfe Research | Steve Fleishman | $49 | $44.2 | +16.6% | Jul 29, 2026 |
| KeyBanc | Sophie Karp | $46 | $43.68 | +9.5% | Jul 23, 2026 |
| Morgan Stanley | David Arcaro | $40 | $43.43 | -4.8% | Jul 22, 2026 |
| BMO Capital | Analyst unavailable | $48 | $43.12 | +14.2% | Jul 15, 2026 |
| Jefferies | Analyst unavailable | $50 | $42.82 | +19.0% | Jun 18, 2026 |
| Truist Financial | Richard Sunderland | $47 | $41.53 | +11.9% | May 18, 2026 |
| Evercore ISI | Analyst unavailable | $45 | $43.52 | +7.1% | May 4, 2026 |
| Wells Fargo | Analyst unavailable | $48 | $42.7 | +14.2% | Apr 21, 2026 |
| Jefferies | Julien Dumoulin-Smith | $49 | $42.82 | +16.6% | Apr 16, 2026 |
| Barclays | Analyst unavailable | $44 | $42.9 | +4.7% | Apr 15, 2026 |
| Mizuho Securities | Analyst unavailable | $44 | $43 | +4.7% | Feb 23, 2026 |
| Morgan Stanley | Analyst unavailable | $37 | $39.59 | -11.9% | Jan 21, 2026 |
| Wells Fargo | Shahriar Pourreza | $47 | $39.71 | +11.9% | Jan 20, 2026 |
| Barclays | Analyst unavailable | $38 | $39.06 | -9.6% | Jan 15, 2026 |
| BMO Capital | Analyst unavailable | $42 | $37.88 | -0.0% | Jan 13, 2026 |
| UBS | Analyst unavailable | $43 | $38.05 | +2.3% | Dec 17, 2025 |
| Morgan Stanley | David Arcaro | $36 | $38.19 | -14.3% | Dec 16, 2025 |
| KeyBanc | Sophie Karp | $41 | $37.31 | -2.4% | Dec 12, 2025 |
| Wells Fargo | Shahriar Pourreza | $44 | $39.74 | +4.7% | Oct 27, 2025 |
| Mizuho Securities | Analyst unavailable | $42 | $40.01 | -0.0% | Oct 21, 2025 |
| Morgan Stanley | Analyst unavailable | $39 | $39.88 | -7.2% | Oct 21, 2025 |
| Barclays | Analyst unavailable | $41 | $40.22 | -2.4% | Oct 21, 2025 |
| UBS | Analyst unavailable | $46 | $39.11 | +9.5% | Oct 10, 2025 |
| Barclays | Analyst unavailable | $40 | $39.46 | -4.8% | Oct 7, 2025 |
| Evercore ISI | Analyst unavailable | $42 | $39.46 | -0.0% | Oct 6, 2025 |
| BMO Capital | James Thalacker | $41 | $38.17 | -2.4% | Oct 2, 2025 |
| Mizuho Securities | Analyst unavailable | $40 | $39.13 | -4.8% | Sep 30, 2025 |
| Morgan Stanley | David Arcaro | $38 | $38 | -9.6% | Aug 21, 2025 |
| Mizuho Securities | Anthony Crowdell | $39 | $38.36 | -7.2% | Jul 25, 2025 |
| Scotiabank | Andrew Weisel | $40 | $38.02 | -4.8% | Apr 25, 2025 |
| UBS | William Appicelli | $37 | $31.99 | -11.9% | Dec 3, 2024 |
| BMO Capital | James Thalacker | $34 | $32.76 | -19.1% | Nov 27, 2024 |
| Scotiabank | Andrew Weisel | $30 | $29.74 | -28.6% | Oct 29, 2024 |
| Barclays | Nicholas Campanella | $29 | $29.57 | -31.0% | Oct 14, 2024 |
| Scotiabank | Andrew Weisel | $28 | $29.7 | -33.4% | Oct 1, 2024 |
| Morgan Stanley | David Arcaro | $32 | $28.64 | -23.8% | Sep 25, 2024 |
| Citigroup | Ryan Levine | $34 | $28.21 | -19.1% | Sep 16, 2024 |
| Bank of America Securities | Ross Fowler | $29 | $27.95 | -31.0% | Sep 12, 2024 |
| BMO Capital | James Thalacker | $28 | $27.09 | -33.4% | Aug 26, 2024 |
| KeyBanc | Sophie Karp | $31 | $28.96 | -26.2% | Jul 22, 2024 |
| BMO Capital | James Thalacker | $33 | $30.5 | -21.5% | Jun 26, 2024 |
| KeyBanc | Sophie Karp | $33 | $30.08 | -21.5% | May 20, 2024 |
| BMO Capital | James Thalacker | $32 | $28.94 | -23.8% | Apr 25, 2024 |
| Morgan Stanley | Analyst unavailable | $31 | $30.53 | -26.2% | Dec 15, 2022 |
| Morgan Stanley | Analyst unavailable | $29 | $29.15 | -31.0% | Nov 11, 2022 |
| Credit Suisse | Analyst unavailable | $34 | $31.75 | -19.1% | Apr 26, 2022 |
| Morgan Stanley | Analyst unavailable | $34 | $32.74 | -19.1% | Apr 20, 2022 |
| Wells Fargo | Analyst unavailable | $36 | $32.08 | -14.3% | Apr 19, 2022 |
| Citigroup | Ryan Levine | $29 | $26.49 | -31.0% | Feb 23, 2022 |
| UBS | Ross Fowler | $30 | $26.72 | -28.6% | Feb 15, 2022 |
| Goldman Sachs | Insoo Kim | $30 | $27.25 | -28.6% | Jan 12, 2022 |
| Scotiabank | Andrew Weisel | $29 | $27.91 | -31.0% | Dec 15, 2021 |
| Guggenheim | Shahriar Pourreza | $29 | $26.16 | -31.0% | Nov 4, 2021 |
Track every rating change on CNP the moment it posts. Free to start.
Start free